Isolation of Anti-Erythropoietin by Automated Immuno-Affinity FPLC using Recombinant EPO

  • Günther Sawatzki
Part of the NATO ASI Series book series (volume 8)

Summary

Recently, the recombinant human glycoprotein, erythropoietin (EPO), has become available in a highly purified form. Erythropoietin of lower purity is normally isolated from urine. This preparation of EPO was used to immunize rabbits. The immunoglobulin-fraction (IgG) of the serum was isolated and further purified by immuno-affinity chromatography. For this purpose, a column was prepared by coupling 3 ug of recombinant EPO to 0.5 ml tresyl-activated SEPHAROSE 4B.The specific anti-EPO antibody fraction was isolated on this column by applying only small samples (400 ug of IgG) and running this column more than 800 times. This was only possible by completely automating the equipment (FPLC-system). One totally automated cycle of 80 runs lasted for about 4 days. After 800 runs the specific IgG fractions were pooled and concentrated by freeze-drying. The total amount of IgG in this pool was about 180 ug protein. Using this technique, it was possible to isolate larger quantities of immuno-affinity purified antibodies on only minute amounts of the recombinant protein. The same technique was applied to isolating immuno-affinty purified EPO on the specific IgG coupled to a similar matrix.The specific antibodies and the recombinant EPO were used in an enzyme-linked immunosorbent assay (dot-ELISA) to follow the purification of EPO. These purified proteins are being used to develop a new ELISA for EPO.

Keywords

Phenol Fluoride Aldehyde Anemia Dition 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Miyake T, Kung CK-H and Goldwasser E (1977). Purification of human erythropoietin. J Biol Chem 252: 5558–5564.PubMedGoogle Scholar
  2. 2.
    Sieber F (1977). Chromatography of human urinary erythro-poietin and granulocyte colony-stimulating factor on insolubilized phytohaemagglutinin. Biochim Biophys Acta 496: 146–154.PubMedGoogle Scholar
  3. 3.
    Spivak JL, Small D, Shaper JH and Hollenberg MD (1978). Use of immobilized lectins and other ligands for partial purification of erythropoietin. Blood 52: 1178–1188.PubMedGoogle Scholar
  4. 4.
    Krystal G, Eaves CJ and Eaves AC (1984). CM affi-gel blue chromatography of human urine: a simple one-step procedure for obtaining erythropoietin suitable for in vitro erythropoietic progenitor assays. Brit J Haematol 58: 533–546.CrossRefGoogle Scholar
  5. 5.
    Okamoto T, Kanamaru A, Hara H and Nagai K (1982). Burst-promoting activity (BPA) without erythropoietin ( Ep) activity in sera of aplastic anemia patients fractionated by chromatofocusing column. Exp Hematol 10: 844–851.PubMedGoogle Scholar
  6. 6.
    Sytkowski AJ and Fisher JW (1985), Isolation and characterization of an anti-peptide monoclonal antibody to human erythropoietin. J Biol Chem 260: 14727–14731.PubMedGoogle Scholar
  7. 7.
    Mok M and Spivak JL(1982).Protease Activity in human urine erythropoietin preparations. Exp Hematol 10:300–306.Google Scholar
  8. 8.
    Dao ML (1985). An improved method of antigen detection on nitrocellulose: in situ staining of alkaline phosphatase conjugated antibody. J Immunol Meth 82: 225–231.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • Günther Sawatzki
    • 1
  1. 1.Dept. of Transfusion MedicineUniversity of UlmUlmGermany

Personalised recommendations